Aditxt, Inc. Files 8-K Current Report
Ticker: ADTX · Form: 8-K · Filed: May 5, 2025 · CIK: 1726711
Sentiment: neutral
Topics: 8-K, disclosure, regulation-fd
TL;DR
Aditxt filed an 8-K on May 5th for an event on May 2nd. Standard disclosure.
AI Summary
Aditxt, Inc. filed an 8-K on May 5, 2025, reporting an event on May 2, 2025. The filing is a current report under Regulation FD and includes financial statements and exhibits. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates Aditxt, Inc. is providing updated information to the SEC, which could include material events or financial updates relevant to investors.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for disclosure purposes and does not appear to contain significant negative or positive news.
Key Numbers
- 001-39336 — SEC File Number (Identifies the company's filing with the SEC)
- 82-3204328 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- May 2, 2025 (date) — Earliest event reported
- May 5, 2025 (date) — Date of report
- Aditx Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- 2834 (sic_code) — Standard Industrial Classification
FAQ
What specific event occurred on May 2, 2025, that necessitated this 8-K filing?
The filing itself is the disclosure of the event, but the specific nature of the event on May 2, 2025, is not detailed in the provided excerpt, only that it triggered a Regulation FD disclosure.
What are the key financial statements or exhibits included in this filing?
The provided excerpt states that 'Financial Statements and Exhibits' are included, but does not list their specific content.
What was the previous name of Aditxt, Inc. and when did the name change occur?
The company was formerly known as Aditx Therapeutics, Inc., with a name change date of November 13, 2020.
What is Aditxt, Inc.'s Standard Industrial Classification (SIC) code?
Aditxt, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Aditxt, Inc.'s principal executive office located?
Aditxt, Inc.'s principal executive offices are located at 2569 Wyandotte Street, Suite 101, Mountain View, CA 94043.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 5, 2025 regarding Aditxt, Inc. (ADTX).